References
- Reif L. Cardiacs and normals: the social construction of a disability. Chronic illness across the lifespan, M Dimond, S Jones. Appleton-Century-Crofts, Toronto 1983
- Kirshner J B. Observations in medical treatment of inflammatory bowel disease. JAMA 1980; 243: 557–63
- Powell-Tuck J, Brown R L, Lennard-Jones J E. A comparison of oral prednisone given as single or multiple daily doses for active procto-colitis. Scand J Gastroenterol 1978; 13: 833–7
- Best W R, Becktel J M, Singleton J W. Rederived values of the eight coefficients of the Crohn's disease activity index (CDAI). Gastroenterology 1979; 77: 843–6
- Harvey R F, Bradshaw J M. A simple index of Crohn's disease I activity. Lancet 1980; 1: 514–5
- Truelove S C, Witts L J. Cortisone in ulcerative colitis: preliminary report in a therapeutic trial. Br Med J 1954; 2: 374–8
- Baron J H, Connell A M, Lennard-Jones J E. Variation between observers in describing mucosal appearance in procto-colitis. Br Med J 1964; 1: 89–92
- Mary J Y, Modigliani R. Development and validation of a Crohn's disease endoscopic index: a prospective multicenter study. Gut 1989; 30: 983–9
- Garrett J W, Drossman D A. Health status in inflammatory bowel disease: biological and behavioural considerations. Gastroenterology 1990; 99: 90–6
- Hay J W, Hay A R. Inflammatory bowel disease: cost of illness. J Clin Gastroenterol 1992; 14: 309–17
- Hunt R H. Quality of Life – the challenges ahead. Scand J i Gastroenterol 1993; 28(Suppl 199)2–4
- Irvine E J. Quality of Life: rationale and methods for developing a disease-specific instrument for inflammatory bowel disease. Scand J Gastroenterol 1993; 28(Suppl 199)22–7
- Drossman D A, Patrick D L, Mitchell C M. HRQOL in inflammatory bowel disease: functional status and patient worries and concerns. Dig Dis Sci 1989; 34: 1379–86
- Farmer R G, Wasley K A, Farmer J M. Quality of Life assessment by patients with inflammatory bowel disease. Cleve Clin J Med 1992; 59: 35–52
- Ware J E, Brook R H, Davies-Avery A. Conceptualization and measurement of health for adults in the health insurance study. Model of Health and Methodology. Santa Monica, Rand Corporation, California 1980; vol 1
- Mitchell A, Guyatt G, Singer J. Quality of Life in patients with inflammatory bowel disease. J Clin Gastroenterol 1988; 10: 306–10
- Torrance G W, Thomas W H, Sackett D LS. A utility maximization model for evaluation of health care programs. Health Res 1972; 7: 118–33
- Love J R, Irvine E J, Fedorak R N. Quality of Life in inflammatory bowel disease. J Clin Gastroenterol 1992; 14: 15–9
- Guyatt G H, Mitchell A, Irvine E J. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989; 96: 804–10
- Archambault A, Feagan B, Fedorak R. The Canadian Crohn's Relapse Prevention Trial (CCRPT). Gastroenterology 1991; 100: A193, Abstract
- Irvine E J, Feagan B, Rochon J. Quality of Life adds dimension to outcome in clinical trials of IBD. Gastroenterology 1992; 102: A640, Abstract
- Deyo R A, Diehr P, Patrick D L. Reproducibility and responsiveness of health status measures. Controlled Clin Trials 1991; 12: 142–158S
- Martin F, Sutherland L, Beck I T. Oral 5-ASA versus prednisone in short-term treatment of Crohn's disease: a multicentre controlled trial. Can J Gastroenterol 1990; 4: 452–7
- Irvine E J, Feagan B, Wong C. Should Quality of Life instruments be self-administered?. Falk Symposium Abstracts 1992, Abstract #25 (Abstract)